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Abstract

PROLONGED STATUS EPILEPTICUS RESULTS IN INCREASED PROTEIN
KINASE A ACTIVITY IN THE RAT PILOCARPINE MODEL

By James McLeod Bracey, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University
Virginia Commonwealth University, 2005

Major Director: Dr. Severn B. Churn
Associate Professor Departments of Anatomy and Neurobiology,
Pharmacology and Toxicology, and Physiology
Director, Molecular Neuroscience Research Facility

This study was conducted to characterize cellular changes occurring during the
progression of status epilepticus (SE) that could lead to the maintenance of increased
membrane excitability. SE was induced by injection of pilocarpine after which rats were
monitored both electrographically and behaviorally. After various lengths of time in SE,
specific brain regions were isolated for biochemical study. SE resulted in an early

vii
maintenance of PKA activity in both cortical homogenate and crude synaptoplasmic
membrane (crude SPM) fractions. At subsequent stages of SE there was a significant
increase in PKA activity in both homogenate and crude SPM fractions. Wester blot
analysis showed that alteration of PKA protein expression was not responsible for the
increase in PKA activity. These results show that SE has a significant durationdependent effect on PKA activity. Combined with other cellular changes these findings,
could represent a mechanism for the formation for potentiated seizure states like epilepsy.

INTRODUCTION
Epilepsy
Epilepsy is a common neurological disorder experienced by roughly 2.5 million
people in the United States alone with greater than 150,000 people developing seizures
and/or epilepsy each year. Overall, epilepsy occurs when there is an imbalance in
signaling contribution between excitatory and inhibitory neurons. This imbalance leads
to excessive excitatory signaling through an increase in glutamatergic (excitatory)
responses, decreased y-aminobutyric acid ([GABAIergic) inhibitory responses, or
possibly a combination of the two. Seizure activity is commonly attributed to a decrease
in the inhibitory effects of GABA receptor mediated channels. Under normal physiologic
conditions, GABA channels allow for the conductance of negatively charged chloride
ions into the cell which counterbalance the effects of incoming positive ions associated
with glutamatergic channels. This influx of chloride helps maintain the cell's normal
electrical activity and membrane potential. When the GABA channel is somehow
altered, the normally occurring inhibition it provides is lost resulting in an over excitation
of the cell.
In epilepsy, most seizures are relatively short lived and end through a process of
self termination. There are some pathologies that result in seizures that do not selfterminate but progress into a neurological insult known as status epilepticus (SE). It is
possible that seizures that are capable of self-termination do so through the effects of

GABA-receptor mediated inhibition and that the inhibitory currents associated with these
channels is the source of the seizure termination. Hosts of studies into antiepileptic drugs
(AEDs) including, but not limited to, benzodiazepines, diazepam, lorazepam and
barbiturates, have shown that these drugs target GABAAreceptors. These drugs work by
enhancing the receptor-mediated inhibition through increased conductance through these
channels. This suggests that these channels are intimately involved in the process of
seizure termination.
Status Epilepticus

SE is generally defined as a seizure, either single or in an intermittent series,
which lasts at least 30 minutes during which time the patient does not regain
consciousness (Bassin et al. 2002). A more current definition states that SE is
characterized by a continuous, generalized, convulsive seizure lasting greater than 5
minutes or two or more seizures during which the patient does not regain consciousness
(Bassin et al. 2002; Lowenstein et al. 1999; Treiman et al. 1998). This shorter time
window is supported by the fact that both clinically and experimentally, AEDs lose their
efficacy over time as SE duration increases. Frontline AEDs must therefore be given as
early as possible during the course of SE to ensure effectiveness.
SE is a highly common neurological emergency affecting greater than 100,000
individuals every year in the United States. SE is also a major medical emergency with a
mortality rate of greater than 20% attributed primarily to anoxia, prolonged seizure and
advanced age (DeLorenzo et al. 1996). It has also been shown that patients with epilepsy
have a two to three fold greater chance of mortality when compared to the general
population (Tomson 2000).

Prolonged and uninhibited excitation causes severe and irreversible damage in
neuronal structures in a variety of pathologies such as cerebral ischemia, Alzheimer's
disease, amyotrophic lateral sclerosis and seizure disorders (Anzai et al. 2003; Blennow
et al. 1978; Butterfield and Boyd-Kimball2005; Carriedo et al. 2000; Sankar et al. 1998),
a process called excitotoxicity. These same types of effectstare seen in SE as well with
neuropathological changes induced by the seizures being confined to those locations
experiencing excessive excitation. In addition, many proteins important for proper
neuronal function have been shown to be affected by SE, including calciumlcalmodulin
dependent protein kinase I1 (CaMKII) (Churn et al. 2000) and protein phosphatase 2B or
calcineurin (CaN) (Kurz et al. 2001).
Cyclic-AMP dependent Protein Kinase A

Another protein of interest is cyclic-AMP dependent protein kinase (PKA). PKA,
a member of the serinelthreonine kinase family, is ubiquitously expressed and mediates
both intracellular signal transduction and intercellular signal transmission (Nguyen and
Woo 2003). PKA is a heteromultimer composed of two regulatory subunits and two
catalytic subunits. When cyclic-AMP (CAMP)binds to the regulatory subunits, the
catalytic subunits are released activating the enzyme leading to the phosphorylation of
endogenous substrates. This enzyme activation can then be maintained through several
mechanisms such as the ubiquitination of the regulatory subunits or phosphorylation of
the regulatory subunit by the catalytic subunit causing the two to have a decreased
binding affinity. This decrease in subunit ratio or binding affinity results in sustained
kinase activity.

Previous studies have shown that high frequency stimulation of synaptic pathways
in the hippocampus can increase cAMP levels thus activating PKA (Chetkovich et al.
/

1991). In addition, adenylate cyclases have been shown to be activated by the Dl
subtype of dopamine receptor resulting in increased cAMP formation (Barone et al.
1990). This increase in cAMP would also have the effect of stimulating PKA.
Activation of PKA has been shown to be important for a variety of neuronal functions
notably in the formation of late stages of long-term potentiation (LTP). Progression into
late-LTP has the effect of changing synaptic systems from learning acquisition to
memory consolidation. PKA facilitates this through increased ion channel function
(Crump et al. 2001; Esteban et al. 2003; Meuth et al. 2002) and new protein synthesis,
among others (Kang and Schuman 1996; Krug et al. 1984; Otani et al. 1989).

The Rat Pilocarpine Model of SE
A variety of models of SE are used, including anti-GABA drugs, glutamatergic
drugs, cholinergic drugs and electrical stimulation (Churn et al. 2000). Damage from
each of these models is similar and indicates that the pathological effects are not model
specific, but due to seizure activity associated with SE. In the following study, the
pilocarpine (pilo) model was used for SE induction in rats. Pilocarpine is a muscarinic
agonist and mimics the action of acetylcholine. Prior to pilocarpine injection,
methylscopolamine, a muscarinic antagonist, is injected to reduce the peripheral, adverse
effects of pilocarpine. A short time following the injection of pilo, discrete seizure
activity can usually be noticed. Typically within 8 to 12 minutes following the onset of
discrete seizure activity, non-terminating seizure activity is noticed. This is defined as
the onset of SE.

This research focuses on the effects of SE on PKA activity. This study was
conducted to characterize the relationship between PKA activity and SE progression over
time. SE was induced in adult rats and allowed to continue for predetermined times up to
and including one hour of SE activity. Electroencephalographic (EEG) recordings were
made throughout each experiment after which, animals were sacrificed and biochemical
assays were performed. EEG was analyzed for total time in SE and time to the start of
each SE phase. In addition to EEG recordings, biochemical assays were performed to
determine if there is an SE duration dependent change in PKA activity. The data suggest
that there is a delayed duration dependent increase in PKA activity seen in the cortex
during SE. This is in concert with the decrease in CaMKII activity seen immediately
upon the induction and the delayed increase in CaN activity seen during SE progression.
The following chapter is a paper that has been submitted for publication in Neurobiology

of Disease. The paper is formatted according to the guidelines set by the journal in
which it will appear.

STATUS EPILEPTICUS RESULTS IN A DURATION-DEPENDENT
INCREASE OF PROTEIN KINASE A ACTIVITY IN THE RAT
PILOCARPINE MODEL
ABSTRACT
This study characterized the effects of status epilepticus (SE) on PKA activity in
the rat pilocarpine model. SE was induced and seizure activity was monitored
electrographically and cellular changes studied biochemically. PKA activity in whole
tissue homogenates as well as crude synaptoplasmic membrane fractions was assessed
through substrate phosphorylation reactions. No significant changes in PKA activity
were observed during early stages of SE. However, as SE progressed, significant
increases in both total and synaptic PKA activity were observed. In addition, there was
no observed increase in PKA protein expression in either homogenate or synaptic
samples. Because increased PKA and other protein kinase activities are associated with
long-term potentiation (LTP), increased PKA activity during SE could result in
maintained potentiation of large numbers of synapses on a whole-brain level. These data
support the hypothesis that PKA plays a role in the progression of SE and possibly in the
process of epileptogenesis

INTRODUCTION
Status Epilepticus (SE) is a life threatening emergency that affects approximately
100,000-150,000 people per year (Bassin et al. 2002; DeLorenzo et al. 1996; Fountain
2000; Goodkin et al. 2003) and has a significant mortality rate (Bassin et al. 2002;
Tomson 2000; Waterhouse et al. 1998). SE is defined as either a continuous seizure
lasting 230 minutes or continuous recurrent seizures without the recovery of
consciousness (Fountain 2000). The definition has been modified in recent years to say
that, in adults and children over 5 years of age, SE should be considered after 25 minutes
of continuous seizure activity or two or more individual seizures between which there is
an incon~pleterecovery to consciousness (Lowenstein and Alldredge 1998; Lowenstein et
al. 1999). This revised definition takes into consideration the fact that most tonic clonic
seizures self-terminate within a 5 minute window (Theodore et al. 1994). In addition, SE
results in several secondary effects such as the loss of efficacy of seizure suppressing
drugs, including benzodiazepines, with prolonged seizure episodes and the development
of spontaneous recurrent seizures through a process known as epileptogenesis. This
observation suggests that as seizure activity progresses, cellular changes occur that
change neuronal physiology. Therefore, understanding the cellular changes that occur
during SE may elucidate the processes that result in epileptogenesis.
Cyclic-AMP dependent Protein Kinase A (PKA) is a ubiquitously expressed
member of the serine-threonine kinase family and is known to mediate intracellular signal
transduction in a variety of animal systems. Notably, PKA has been associated with
mediation of both short-term synaptic facilitation via reversible phosphorylation of ion
channels as well as long-term facilitation through modulation of gene expression and

protein synthesis (Bailey and Kandel 1993; Hawkins et al. 1993; Kandel2001). PKA has
been shown to affect both excitatory and inhibitory neuronal signaling and exhibits
complementary as well as antagonistic modulatory effects with respect to
calcium/calmodulin dependent protein kinase I1 (CaMKII) and protein phosphatase 2B or
calcineurin (CaN). For example, PKA has been shown to both enhance and inhibit
GABAAreceptor currents (Kapur and Macdonald 1996; McDonald and Moss 1997)
while the action of CaMKII increases agonist-evoked inhibitory currents (Churn and
DeLorenzo 1998; Churn et al. 2002; Kapur and Macdonald 1996; Wang et al. 1995; Wei
et al. 2004) as well as increases conduction through excitatory glutamate receptors (Fink
and Meyer 2002; Poncer et al. 2002; Wang and Kelly 2001). In addition, PKA has been
shown to have an inhibitory effect on protein phosphatase 1 (PPl) activation by CaN
(Vinade and Dosemeci 2000). PKA has been extensively studied and has been shown to
have altered expression or activity in a variety of pathologies. For instance, in cerebral
ischemia models there is a differential activation of PKA and subsequent CREB
phosphorylation in peri-ischemic and ischemic areas (Tanaka 2001). Disruption of
hippocampal circuits, used as a model of neuronal reorganization, results in the upregulation of several genes involved in signal transduction including PKA (Anguelova et
al. 2000). In addition, PKA has been associated with the abnormal tau phosphorylation
and neurofibrilary tangle formation seen in Alzheimer's disease (Bonkale et al. 1999).
Despite these findings, little research has been done into PKA's role in status epilepticus.
This study utilized electrographic and behavioral monitoring in the Pilo-SE model
and tracked changes in PKA activity during the progression of status epilepticus.
Following the development of SE, the data show that PKA activity is maintained while in

later stages of SE, there is a significant increase in PKA activity. The data suggest that
the modulation of PKA activity is involved in cellular changes associated with prolonged
seizure activity in SE.

MATERIALS AND METHODS
Materials
All materials were reagent grade and purchased from Sigma Chemical Company
(St. Louis, MO, USA) and Fisher Scientific (Pittsburgh, PA, USA) unless otherwise
stated. [ y - 3 2 ~was
] ~purchased
~ ~
from Perkin Elmer Life and Analytical Sciences
(Boston, MA, USA). Adult male Wistar rats were purchased from Harlan Laboratories
(Indianapolis, IN, USA). SignaTECT PKA assay system components were purchased
from Promega (Madison, WI, USA). KT-5720 was purchased CalBiochem (San Diego,
CA, USA). Affinity purified rabbit polyclonal anti-PKAP catalytic subunit was obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Purified goat polyclonal antiPKA RII subunit and mouse monoclonal anti-P-tubulin (clone AA2) were obtained from
Upstate (Lake Placid, NY, USA).
Methods
Pilocarpine Model of Status Epilepticus
All animal use procedures were in strict accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and were approved by the
Virginia Commonwealth University Institutional Animal Care and Use Committee.
Wistar rats were handled following arrival from Harlan Laboratories, for acclimation
prior to drug treatment. One week prior to the induction of SE, 4 surface electrodes were
implanted into the skull of rats under ketamine anesthesia, as described previously
(Chum 2005; Singleton et al. 2005b). Two frontal electrodes were implanted over frontal
cortex [3S m m ant. Bregma, h2.5mm L/R (F 1/F2)]. Two posterior electrodes were
implanted over parietal cortex and hippocampus [2.0mm post. Bregma, A2.5mm L R

(Pl/P2)]. A 5" electrode was fixed onto the surface of the skull as a ground. The
electrodes were secured in place with dental acrylate and the animals were allowed at
least 5 days to recover from surgery before experiments were performed.
Induction of Status Epilepticus
Control and experimental animals were hooked up to EEG machines (Viking IV,
Nicolet, Madison, WI) and baseline EEG recordings were obtained for 10 minutes
following scopolamine injection. 30 minutes prior to the injection of pilocarpine,
methylscopolamine, a muscarinic antagonist, was administered i.p. (1 mglkg) to reduce
adverse peripheral affects of the pilocarpine. SE was induced in experimental animals by
intraperitoneal injection of 375 mglkg pilocarpine HC1 (Pilo), a muscarinic agonist.
Behavioral and encephalographic activity was recorded throughout the procedure using
video and EEG recording. Once initial seizure activity was observed, the time was noted
and rats were allowed to seize for specific amounts of time before the animals were
processed. These time points consisted of 10,20,40 and 70 minutes post first discrete
seizure. Since this lab has characterized SE onset as being approximately 10 minutes
after the first discrete seizure (Singleton et al. 2005b), these times approximate 0, 10, 30
and 60 minutes of SE, respectively. Electrographic data was analyzed for SE
susceptibility, number of discrete seizures, death rate, time to first seizure, time from first
seizure to SE, average duration of SE for each animal, percent of time spent in each stage
of SE for each animal, and once in SE, seizure severity. Spectral analysis of EEG
activity was performed using Insight I1 software (Persyst Corporation Prescott, AZ).
After induction of SE, seizure activity was characterized according to the system of
Handforth and Treiman (Handforth and Treiman 1995a; Handforth and Treiman 1995b).

Seizure severity was determined based on the amount of time spent in each stage of SE.
Behavioral seizures were assessed according to the scale of Racine (Racine 1972).
Brain Region Isolation
Brain region isolation was performed as previously described with slight
modifications (Churn et al. 2000). Specific brain regions (cortex and hippocampus) were
dissected away on ice and immediately homogenized into an iced-cold buffer containing
50mM Tris-HC1 (pH 7.4), 7mM EGTA, 5mM EDTA, 320mM sucrose, 1mM
dithiothreitol (DTT), and 0.3mM phenylmethylsulfonyl fluoride (PMSF). The brain
regions were homogenized by 10 up and down strokes using a teflon pestle at 12,000
rpms (Fordham Bethel, CT). A portion of the sample was then aliquoted and frozen at 80°C until processed for biochemical analysis.
Isolation of Subcellular Fractions
Subcellular fractions were isolated by a differential centrifugation procedure as
modified from Edelman et al. (Edelman et al. 1985). Brain region homogenates were
centrifuged at 5,000 x g for 10 min (Beckrnan JA-17 rotor) to produce a crude nuclear
pellet (PI). The supernatant from the spin (Sl) was then centrifuged for 30 min at 18,000
x g to produce a crude synaptoplasmic membrane/mitochondrial pellet (crude SPM),
which was resuspended in homogenization buffer. All fractions were rapidly separated
into aliquots and stored at -80°C for later use.
Substrate Phosphorylation
Brain region homogenates and crude SPM fractions were normalized for protein
concentration using the Bradford method with BSA as the standard (Bradford 1976).
PKA dependent phosphorylation reactions contained sample (1 50 pg), PKA Assay Buffer

5X, [y-32PlATP in 0.5mM ATP, PKA Biotinylated Peptide Substrate 100mM, *CAMP
0.025mM,

* dH20. ATP mix was made by adding 0.05pL [y-32PlATP ((3,00OCi/mmol)

IOpCiIpl) to 0.5mM cold ATP (5p1) per reaction. Final volume of all reaction tubes was
25pL. Following inclusion of PKA buffer, PKA substrate, dHzO for basal reactions or
CAMPfor maximal reactions, [y-32PlATP (5pL) was added and the reaction tubes
allowed to incubate in a 30' C water bath for 5 minutes. After 5 minutes 5pL of protein
sample was added to each tube. Tubes were then allowed to incubate in a 30°C water
bath for an additional 5 minutes. The reactions were then stopped via the addition of
7.5M guanidine hydrochloride (12.5pL). Basal and maximally stimulated reactions were
performed in triplicate. 1OpL aliquots were then taken from each tube and spotted on a
biotin capture membrane. Membranes were then washed to remove unbound phosphates.
Washes were as follows: Four washes in 2M NaC1,4 washes in 2M NaCl with 1%
&Po4 and 2 washes in deionized water. Following drying the biotin membrane sections
were placed in scintillation vials, 2ml of cytoscint was added and the reactions were
counted using a Beckrnan LS 2800 scintillation counter.
Immunodetection of PKA Regulatory and Catalytic subunits
Western analysis was performed to quantify the protein levels of PKA regulatory and
catalytic subunits essentially as described previously (Churn et al. 1995; Churn et al.
1992; Singleton et al. 2005b). Briefly, homogenate and crude synaptic cortical and
hippocampal fractions were resolved on SDS-PAGE and transferred to a nitrocellulose
membrane using the Trans-blot system (Bio-Rad, Hercules, CA, USA). The
nitrocellulose membranes were then immersed for 1 h in blocking solution containing
phosphate-buffered saline (PBS, pH 7.4), 0.05% (vlv) polyoxyethylene sorbitan

monolaurate (Tween-20), 50 g/L Bio-Rad blotting grade dry milk, and horse serum
(Vector Laboratories Inc., diluted 50 mLI10 mL). The nitrocellulose membranes were
then incubated with primary antibody in blocking solution at 4OC overnight. Primary
antibodies were diluted 1:1000 in PBS with Tween-20 and 50g/L nonfat dry milk.
Membranes were washed three times in a wash solution containing PBS and Tween-20.
The nitrocellulose membranes were then reacted with an appropriate secondary antibody
(1:5000) in blocking solution for 1 hour. Nitrocellulose was then washed three times in
PBS for 10 min per wash. Blots were developed using ECL dectection (Pierce,
Rockford, IL). Chemiluminescence was detected by using Kodak autoradiographic film.
Specific immunoreactive bands were quantified by computer-assisted densitometry using
a BioRad GS-800 calibrated densitometer and the BioRad Quantity One software
(Version 4.4.0) as described previously (Churn et al. 2000; Singleton et al. 2005b). As a
protein loading control, western blot membranes were probed with an anti-P-tubulin
antibody (1 :1000).

Statistical Analysis
Data was analyzed using GraphPad Prism version 4.0 (GraphPad Software, San Diego,
CA USA). Student's t tests were used for all single, parametric comparisons. For
multiple comparisons, one-way ANOVA with a Tukey post hoc analysis with 95%
confidence was used.

RESULTS
Time-dependence of Pilo-induced SE

Monitoring of SE phases was performed through electrographic and video
recordings (see Materials and Methods). Baseline electrographic recordings were
obtained following injection of scopolamine with activity consisting of low amplitude,
asynchronous spikes. Approximately 20 minutes after pilocarpine injection,
electrographic activity slowed and amplitude increased finally culminating in overt ictal
activity (Figure 1A). During seizure induction baseline data gave way to anincrease in
amplitude and decrease in frequency. Spectral analysis of ictal activity during the first
discrete seizure indicated a near 10-fold increase in the delta component. This denoted
the onset of the discrete seizure phase. A typical seizure progression was observed as
reported previously including behavioral manifestations of decreased ambulation,
uncontrolled salivation, tonic/clonic movements, rearing and falling and myoclonus
(Singleton et al. 2005b). These characteristics represent behavioral scores of between 1
and 4 on the Racine scale (Racine 1972). Each discrete seizure was characterized by a
gradual increase in electrographic activity which peaked for 10-40 seconds. This was
followed by a sudden drop back to baseline levels (Singleton et al. 2005b). Typically,
pilocarpine treated rats developed 2-3 discrete seizures lasting 20-50 seconds each. A
small population of animals displayed discrete seizure activity but did not develop overt
SE (Sz-NOSE). These animals were separated and used as a No-SE surgery control group
as described before (Singleton et al. 2005a).
In animals that developed SE, EEG activity for each animal was analyzed for all
SE seizure stages including WaxIWane ( W N ) (Figure 1B), FastlSlow (FIS) (Figure 1C),

Early Continuous (EC) (Figure 1D) and Fast Spiking with Pauses (FSIP) (Figure lE), as
described (Singleton et al. 2005b). EEG from pilocarpine treated rats, experiencing 10
minutes to over one hour of time spent in SE, was reviewed and the times to the start of
each seizure phase listed above were determined. Time to start of each seizure phase was
calculated using the initiation of the first discrete seizure asdime zero (Singleton et al.
2005b). Times for all rats were averaged together since the time each rat was sacrificed
has no direct bearing on what seizure phase was entered. The average time for rats to
enter WIW was 6 minutes 23 seconds (k 69 sec). The average time to the start of FIS was
10 minutes 57 seconds (h 79 sec). This average was slightly skewed due to the fact that
one rat entered FIS prior to entering the WIW phase and did so only 41 seconds following
the start of the first discrete seizure. Removing this data yielded a new average of 12
minutes 45 seconds to the onset of FIS.
Following the FastISlow period there was a significant decrease in the numbers of
animals reaching later stages of SE. Animals that entered EIC did so in an average of 19
minutes 30 seconds (k 3 min. 5 sec. sec). Further, the animals that entered F S P did so in
an average of 28 minutes 34 seconds (*4min. 42sec.). These data show that, as SE
seizure activity progresses, there is a positive correlation between length of time in SE
and seizure phase attained.
SE-induced Activation of CAMP-dependent Protein Kinase
Maintenance of PKA Activity during SE in cortical and hippocampal homogenate
PKA activity during specific durations of status epilepticus was assessed in whole
tissue homogenates using an exogenous substrate (Figure 2). Rats were allowed to seize
for predetermined periods of time after which the cortex and hippocampus were isolated,

homogenized and used to test for PKA activity through a substrate phosphorylation
procedure (see Materials and Methods).
The basal activity level of PKA in control cortical homogenates was
approximately 0.034 pmol P04/pg protein (n=9) (Figure 2A). Under maximally
stimulated conditions control cortical samples showed a roughly ten-fold increase in PKA
activity, 0.30 pmol P04/pg protein (n=9) (Figure 2A). To confirm the specificity of the
assay for measuring PKA activity we included KT-5720, a specific inhibitor of PKA, into
parallel reaction vessels. Using control homogenate samples the inhibitor was added
with its final concentration equaling 10 pM. Treatment of these samples produced
significant decreases in both basal and maximally treated reactions (data not shown).
SE did not modulate basal PKA activity at any time point studied (Figure 2A).
However, SE did result in altered maximal basal activity. Samples from animals
experiencing 10 minutes of SE were observed to have roughly the same level of activity
as is found in control samples (0.335 pmol P04/pg protein ( p 0 . 0 5 , One-way ANOVA)).
In 20-minute animals, the maximal PKA activity was approximately 0.441 pmol P04/pg
protein. While this is an increase of about 37%, it was not statistically significant when
compared to control levels (n=8, p>0.05). Later in the progression of SE, maximal levels
of PKA activity continue to remain higher than controls with 40-minute sample maximal
PKA activity roughly 0.399 pmol P04/pg protein (33% increase) (n=6, p>0.05). The
level of activity seen in 70-minute samples was observed to be approximately 0.46 pmol
P04/pg protein, a 53% increase that was significantly different when compared to control
samples (n=6, p<0.001). The data were also compared with data from animals that had
discrete seizures but did not go into status epilepticus (Sz-NOSE). Sz-NOSEanimals had

maximal PKA activity levels of roughly 0.26 pmol P04/pg protein, a 14% decrease but
not significantly different from control animals (n=6, pB0.05). This is analogous to the
previous findings that CaMKII activity does not change in animals displaying discrete
seizures but not entering SE (Singleton et al. 2005a).
Hippocampal homogenates were examined for PKA,activity as described above
(Figure 2B). Basal PKA activity in the hippocampal homogenate samples was 0.006
pmol P04/pg protein (n=lO). Maximally stimulated activity was approximately 4-fold
higher than basal activity (0.021 pmol P04/pg protein) and was significantly different
when compared to the basal reaction activity levels (n=10, p<0.001). Basal levels of
PKA activity were not significantly different between control samples and any of the
time points studied (n=39, p>0.05). As was observed in the cortical samples, maximal
PKA activity was maintained over the early 10 and 20-minute time points (n=6, 0.022
pmol P04/pg protein and n=7, 0.022 pmol P04/pg protein, respectively, p>0.05).
Samples from animals experiencing 40 and 70 minutes of SE showed slight increases in
PKA activity when compared to control animals with 40-minute samples having maximal
PKA activity levels around 0.024 pmol P04/pg protein and 70-minute samples PKA
activity around 0.025 pmol P04/pg protein. Neither time point showed a significant
change when compared to control samples (n=6 and n=6 respectively, p>0.05). Similar
to the data observed for cortical homogenates, hippocampal samples from Sz-NOSE
animals showed no significant change in maximal PKA activity when compared to
control values (0.016 pmol P04/pg protein, n=4, p>0.05).
Immunodetection of PKA levels in cortex and hippocampus homogenate

A possible mechanism to modulate PKA activity can be accomplished through an
increased enzyme expression or change in relative expression levels of regulatory subunit
versus catalytic subunit. To determine whether the observed increase in PKA activity
seen in whole cell homogenates was due to an increase in PKA protein levels or relative
decrease in regulatory subunits versus catalytic subunits, western analysis was performed
on whole cell homogenates fiom the cortex and hippocampus utilizing commercially
available antibodies towards both the catalytic and regulatory subunits of PKA (see
Materials and Methods). Control, 20,40 and 70 minute samples were examined to
determine any changes in protein levels during a time course of SE. When probing for
PKA catalytic subunits in cortical homogenate (Figure 3 A, B), the relative density for
control samples was 0.46. The 20-minute relative density was 0.36, a 12% change and
the 40-and 70-minute relative densities were 0.43 and 0.35 respectively (4.8% and 15%
changes n=4 each, p>0.05). In hippocampal samples (Figure 4 A, B), similar results were
obtained. The relative density for control samples was 0.67 and all time points studied
had optical densities of between 0.47 and 0.53. While the differences amounted to
changes of 20-30% none were significant when compared to either control or each other
(n=4 each, p>0.05). Thus, the net increase in PKA activity could not be explained by an
increase in catalytic subunit expression.
To determine if a selective loss of PKA regulatory subunit could explain the
apparent increase in activity, total subunit protein levels were assessed. In cortical
homogenates (Figure 3 C, D), control samples had an average optical density of 1.54
while 20-minute samples had an optical density of 1.59,40-minute samples 1.69 and 70minute samples had an optical density of 1SO. No cortical homogenate samples

displayed a density that was significantly different when compared to either control or
each other (n=16, p>0.05). Probing for PKA regulatory subunits in hippocampal
homogenates also displayed results similar to those seen for the catalytic subunits (Figure
4 C, D). Control samples had an average optical density of 2.21 while 20,40 and 70minute samples had optical densities of 1.91, 1.85 and 1.70 respectively. These represent
decreases of between 14% and 24% but were not statistically significant when compared
to control levels or each other (n=16, p>0.05). Thus, altered catalytic subunit protein
expression was not the primary mechanism to increase PKA activity.

Maintenance of PKA activity during SE in cortical and hi~pocampalbrain subcellular
fractions
Due to the early maintenance and subsequent increase of PKA activity on the
whole cell homogenate level, we wanted to determine if there were any selective changes
in PKA activity in the crude synaptic membrane fraction. Subcellular fractions were
made from brain homogenates including those for 10,20,40 and 70 minute samples post
first discrete seizure (See Materials and Methods). Basal levels of PKA activity in the
cortical crude SPM samples was approximately 0.004 pmol P04/pg protein (Figure 5A),
a significantly lower level when compared to homogenate samples. Control maximal
levels of PKA activity were 0.02 pmol P04/pg protein, a five-fold increase over the basal
samples (n=6, p<0.001). Again, basal levels of PKA activity for all time points tested
were not significantly different when compared to control values (n=32, p>0.05).
Similar to the observations made in the cortical homogenate, PKA activity levels
were maintained during the initial phases of SE progression. Samples from 10-minute

animals had maximal PKA activity levels of 0.01 8 pmol P04/pg protein while 20-minute
samples had activity levels of 0.0 19 pmol P04/pg protein. Neither of these were
significant changes when compared to control values. As SE progressed into later stages,
the crude SPM PKA activity level increased in a manner similar to the homogenate. In
40-minute samples the maximal PKA activity was 0.034pmol P04/pg protein, a 70%
increase over the control value (n=6, p<0.05). 70-minute samples had an activity level of
0.03 1 pmol P04/pg protein (n=6, p>0.05) which was a 55% increase over control.
Crude SPM fractions from the hippocampus displayed a similar maintenance of
PKA activity throughout the time course of SE (Figure 5B). Basal levels of PKA activity
in control hippocampal crude SPM fractions was 0.004 pmol P04/pg protein while
maximal activity was 0.01 3 pmol P04/pg protein (n=8). Again both levels were
significantly lower than those seen in homogenate samples. Basal levels for all
experimental time points were not significantly different from the control value.
Maximal PKA activity for all time points was not significantly different from the control
maximal value. The 10-minute samples had an activity of 0.0 12 pmol P04/pg protein
(n=5), 20-minute samples had activity of 0.01 1 pmol P04/pg protein (n=8), 40-minute
samples had activity of 0.009 pmol P04/pg protein (n=4) and 70-minute samples had
maximal PKA activity of 0.01 1 pmol P04/pg protein (n=10). Similar to all other
fractions studied, hippocampal crude SPM samples showed a maintenance of PKA
activity but without the increase in activity during later stages of SE progression.
Immunodetection of PKA in subcellular fractions
Since PKA affects many substrates found in the synapse and has been shown in
this study to have an increased level of activity in subcellular fractions at later stages of

SE, it was important to determine if the increased activity was due to a translocation of
kinase to the synaptic region. Western analysis was performed to determine PKA protein
levels in the crude SPM fractions at specific time points post first discrete seizure.
Control, 20,40 and 70-minute samples were used to probe for both catalytic and
regulatory subunit expression (Figures 6-7). When probing,for catalytic subunits, optical
density in cortical control crude SPM was 0.69 (Figures 6A, B). Densities for 20 and 70minute time points were roughly the same as control with values of 0.61 and 0.67
respectively. These changes were only 3% and 12% respectively and were not
statistically significant (p0.05). The 40-minute samples however, had an average
optical density of 0.18. This was a decrease of about 75% (p<0.05).
As was the case for homogenate samples, western blots were probed for PKA
regulatory subunit expression over the time course of SE progression (figure 6 C, D).
While optical density values were observed to be lower than those associated with the
homogenate samples the results obtained were very similar to those for the PKA catalytic
subunit expression in the same tissue. Control samples had an average optical density of
0.96 which was equaled by the 20-minute animals which also had an average optical
density of 0.96. Similar to the PKA catalylic subunit, the optical density for 40-minute
samples was observed to decrease by about 47% to 0.5 1. This was followed by a return
near to control levels for the 70-minute samples with an average optical density of 0.82.
While there is a large decrease at 40-minutes, none of the time points were statistically
different when compared to either control or each other (n=16, p>0.05).
Wanting to ensure that these decreases in 40-minute samples were not due to a
protein loading error, blots were probed for levels of P-tubulin, a neuronal specific

marker. Average optical density for control samples was 1.23 while those for 20,40 and
70-minute samples were 1.20, 1.1 1 and 1.13 respectively. None of these were
statistically significant changes when compared to control samples. ( p 0 . 0 5 , one-way
ANOVA) This indicates that the loss of PKA regulatory and catalytic subunits seen after
40 minutes of SE represents some form of major cellular change in enzyme expression.
Attempts were made to identify a subcellular pool with an increased level of PKA at 40minutes but no significant changes could be seen. If PKA translocates to the cytosol it is
possible that PKA native to the cytosol could mask any increase in PKA from the
synapse.
Despite having no significant changes in PKA activity, hippocampal crude SPM
samples were probed for PKA catalytic and regulatory subunit expression levels. When
probing for catalytic subunits, hippocampal crude SPM fractions displayed results similar
to those seen in the homogenate san~ples(Figure 7 A, B). Average optical densities for
control samples and experimental time points were around 1.O. Control samples had a
density of 1.06 while 20,40 and 70-minute samples had densities of 1.08, 0.94 and 1.00,
respectively. These differences from control densities represented changes of between
1% and 12% only and were not statistically significant.
When analyzing regulatory subunit expression in the hippocampal fractions, a
trend similar to that of the cortical samples was observed (Figure 7 C, D). Control
densities were roughly equal to 0.98. As was noticed in the homogenate, a small
decrease was observed at 20 minutes with a density of 0.79. A further decrease was seen
at 40 minutes to a density of 0.64 while the 70-minute samples had a density of 0.85.

While these differences accounted for changes between 14% and 45%, none were
statistically significant when compared to controls (n=16, p>0.05).

Figure 1. Seizure Progression in the Rat Pilo-SE model ,
Typical electrographic progression during SE induction. A) Following
pilocarpine injection, discrete seizure activity was observed consisting of small increases
in amplitude over baseline progressing to higher amplitude, lower frequency activity.
This was followed by an abrupt ending. B) Roughly 7 minutes after observation of the
first discrete seizure, seizure activity progressed into a waxlwane spike frequency. This
phase denoted the onset of SE. C) Following waxlwane rats typically entered a fastlslow
phase within 13 minutes of the start of the first discrete seizure. This phase was
characterized by high amplitude, high frequency spiking followed by low amplitude, low
frequency spiking. D) The next phase, early continuous, typically commenced within 2 1
minutes and was characterized by continuous high frequency, high amplitude spiking. E)
Fast spiking with pauses was the final phase of SE observed in this population of animals
and commenced roughly 30 minutes post first discrete seizure.

Seizure progression in the Rat Pilo-SE model

Figure 2A. Prolonged SE activity results in increased PMA activity in cortical
homogenates.
Cortical homogenates were studied for basal (white bars) and maximally
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post
first discrete seizure. In all samples, a statistically significant CAMP-induced PKA
activity was observed compared to basal phosphorylation levels (p<0.001, one-way
ANOVA). There was no SE-induced effect on basal PKA activity at any time point
studied. Kinase activity in cortical homogenates was not significantly different from
control during the early 10 and 20-minute time points of SE. An increasing trend was
observed between 20,40 and 70-minute animals with the 70-minute samples displaying a

53% increase in maximal activity. PKA activities of animals that displayed discrete
seizures but did not progress into SE (Sz-NOSE)were also analyzed. (*** denotes
p<0.001 compared to control maximal values)
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Prolonged SE results in increased PKA activity in cortical homogenates

Figure 2B. Prolonged SE results in maintenance of PKA activity in hippocampal
homogenates.

Hippocampal homogenates were studied for basal (white bars) and maximally
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post
first discrete seizure. In all samples a statistically significant CAMP-induced PKA
activity was observed compared to basal phosphorylation levels (p<0.001, one-way
ANOVA). There was no SE-induced effect on basal PKA activity at any time point
studied. Hippocampal homogenates displayed the same relative trend in increasing PKA
activity for maximally stimulated samples, however, none of these changes were
significantly different from control activity. PKA activities for animals that displayed
discrete seizures but did not progress into SE (Sz-NOSE)were also analyzed.
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Prolonged SE results in maintenance of PKA activity in hippocampal homogenates

Figure 3A. SE did not result in an altered PKA catalytic subunit expression in
cortical homogenates.

Western blot analysis was used to determine if the SE-induced increase in PKA
activity was due to an increase in the catalytic subunit (42kD) expression. Figure 3A
shows cortical homogenate samples for control, 20,40 and 70-minute time points. As the
blot indicates, there is no significant difference between control and seizure rats for any
time point studied.

SE did not result in an altered PKA catalytic subunit expression in cortical
homogenates

Figure 3B. SE did not result in significantly altered PKA catalytic subunit
expression in cortical homogenates.
Slight variations between control and SE animals were observed for PKA
catalytic subunit expression in cortical homogenates. However, none of these changes
were statistically significant when compared to control, nor were they significant when
compared to one another (n=4 for all samples). This demonstrates that the increase in

PKA activity observed in cortical homogenate is not due to an increase in catalytic
subunit expression.
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SE did not result in significantly altered PKA catalytic subunit expression in
cortical homogenates

Figure 3C. SE did not induce a decrease in PKA regulatory subunit expression in
cortical homogenate.

Western blot analysis was used to determine if the SE-induced increase in PKA
activity was due to a relative decrease in PKA regulatory subunit (52kD) expression.
Cortical homogenate samples for control, 20,40 and 70-minute animals are shown here.
The blot indicates that there is no significant difference in regulatory subunit expression
between control and any time point studied.

SE did not induce a decrease in PKA regulatory subunit expression in cortical
homogenates

Figure 3D. SE did not result in significantly altered PKA regulatory subunit
expression in cortical homogenate.
No statistically significant differences in PKA regulatory subunit expression were
observed between control samples and any of the time points studied (n=4 for all
samples). This indicates that a loss of regulatory subunit expression is not the cause of
the increased PKA activity.
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SE did not result in significantly altered PKA regulatory subunit expression in
cortical homogenate

Figure 4A. SE did not result in altered PKA catalytic subunit expression in
hippocampal homogenate.
Western blot analysis was used to determine if SE-induced maintenance of PKA
activity was due to an increase in PKA catalytic subunit expression. This figure shows
hippocampal homogenate samples for control 20,40 and 70-minutes time points. This
blot indicates that there was no significant difference between control and seizure rats for
any of the time points studied.
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SE did not result in altered PKA catalytic subunit expression in hippocampal
homogenate

Figure 4B. SE did not result in significantly altered PKA catalytic subunit
expression in hippocampal homogenate.
While there is an apparent trend towards decreasing levels of PKA catalytic
subunit expression in hippocampal homogenates, there was no statistical significance
between control and any time point studied. This shows that, while there was no increase
in PKA activity in these samples, there was no significant change in the level of protein
expression either. (n=4 for all samples)
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SE did not result in significantly altered PKA catalytic subunit expression in
hippocampal homogenate

Figure 4C. SE did not result in altered PKA regulatory subunit expression in
hippocampal homogenate.
Western blot analysis was used to determine if the maintenance of PKA activity
during SE seen in hippocampal homogenate was due to a decreased expression of PKA
regulatory subunits. This blot shows hippocampal homogenate samples for control, 20,

40 and 70-minute animals. Probing for PKA regulatory subunits indicates that there is no
significant difference between control samples and any time point studied.

SE did not result in significantly altered PKA regulatory subunit expression in
hippocampal homogenate

Figure 4D. SE did not result in significantly altered PKA regulatory subunit
expression in hippocampal homogenate.
Presented here is a graphical representation of PKA regulatory subunit protein
levels represented in the previous western blot. While a trend towards decreasing protein
expression is noticed, none of the time points studied displayed a significant difference
from control. (n=4 for all samples)
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SE did not result in significantly altered PKA regulatory subunit expression in
hippocampal homogenate

Figure 5A. Prolonged SE results in increased PKA activity in cortical crude SPM
fractions.
Cortical crude synaptic membrane (crude SPM) fractions were studied for basal
levels (white bars) and maximally stimulated (black bars) levels of PKA activity in
Control, 10,20,40 and 70-minute animals. There was no SE-induced effect on basal
activity levels. All samples showed a significant increase in PKA activity between basal
and CAMP stimulated samples (p<0.001, one-way, ANOVA). PKA activity was
maintained over the early stages of SE in the cortex but displayed a significant increase in
activity at 40-minutes (* represents statistical significance of p<O.O5 when compared to
control maximal values). An increase was also noted at 70-minutes but this was not
significant.
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Prolonged SE results in increased PKA activity in cortical crude SPM fractions

Figure 5B. SE results in maintenance of PKA activity in hippocampal crude SPM
fractions.
Hippocampal homogenates were studied for basal (white bars) and maximally
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post
first discrete seizure. In all samples, a statistically significant CAMP-induced PKA
activity was observed compared to basal phosphorylation levels (p<0.001, one-way
ANOVA). There was no SE-induced effect on basal PKA activity at any time point
studied. Hippocampal homogenates displayed the same relative trend in increasing PKA
activity for maximally stimulated samples; however, none of these changes were
significantly different from control activity.
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Figure 6A. SE results in differential effects on PKA catalytic subunit expression in
cortical crude SPM fractions.

To determine if an increase in PKA catalytic subunit expression was responsible
for the SE-induced increase in PKA activity in cortical crude SPM fractions, western blot
analysis was performed. This blot shows cortical Crude SPM fractions for control, 20,40
and 70-minute animals. PKA catalytic subunit expression remains relatively stable in the
20 and 70-minute samples. Interestingly, there is a 75% decrease in catalytic subunit
expression at 40-minutes. This decrease in protein expression combined with the
observed increase in kinase activity at the same time point indicates that PKA activity is
significantly altered during the course of SE.

SE results in differential effects on PKA catalytic subunit expression in cortical
crude SPM fractions

Figure 6B. Late stages of SE result in differential effect8 on PKA catalytic subunit
expression in cortical crude SPM fractions.

PKA catalytic subunit expression in 20 and 70-minute samples is shown to
experience no significant change when compared to control. 40-minute samples,
however, show a statistically significant 75% decrease in expression of catalytic subunits
(All n=4 and * denotes p<0.05). To ensure that this result was not due to protein loading
error, blots were probed for P-tubulin. No differences were noted in P-tubulin expression
for any time point studied. This confirms the decreased PKA concentration to be an
accurate result. The return to near control values at 70-minutes indicates that there could
be some form of PKA translocation away from the synapse at 40-minutes with a
subsequent return of protein. Degradation and synthesis of new proteins should not be
ruled out however.
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Late stages of SE result in differential effects on PKA catalytic subunit expression in
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Figure 6C. SE results in differential effects of PKA regulatory subunit expression in
cortical crude SPM fractions.
To determine if a decrease in PKA regulatory subunit expression was responsible
for the SE-induced increase in PKA activity in cortical crude SPM fractions, western blot
analysis was performed. This blot shows cortical Crude SPM fractions for control, 20,40
and 70-minute animals. PKA catalytic subunit expression remains relatively stable in the
20 and 70-minute samples. Similar to the results seen for catalytic subunit expression,
there is a 45% decrease in regulatory subunit expression at 40-minutes.

SE results in differential effects on PKA regulatory subunit expression in cortical
crude SPM fractions

Figure 6D. Late stages of SE result in differential effects on PKA regulatory
subunit expression in cortical crude SPM fractions.

This figure shows that PKA regulatory subunit expression is maintained,
compared to control, in 20 and 70-minute samples. Similar to the results seen for
catalytic subunits, PKA regulatory subunit expression is observed to decrease at 40minutes. This decrease (45%) is not significant when compared to control and is smaller
than the decrease associated with catalytic subunits. Here too, the results suggest either a
translocation of PKA away from the synapse with a subsequent return or the possibility
of protein degradation and then synthesis.
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Figure 7A. Prolonged SE does not result in altered PKA, catalytic subunit
expression in hippocampal crude SPM fractions.

To determine if any alterations in PKA catalytic subunit expression were
observed in hippocampal crude SPM fractions, western blot analysis was performed.
Samples from control, 20,40 and 70 minute samples showed no significant differences in
levels of catalytic subunit expression when compared between one another.

Prolonged SE does not result in altered PKA catalytic subunit expression in
hippocampal crude SPM fractions

Figure 7B. Prolonged SE does not result in significantly,altered PKA catalytic
subunit expression in hippocampal crude SPM fractions.
While there were some minor variations in PKA catalytic subunit expression in
cortical crude SPM between control samples and each time point tested, none were
significant. This data mirrors the findings that PKA activity is maintained but does not
increase in these fractions.
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Figure 7C. SE does not result in altered PKA regulatory subunit expression in
hippocampal crude SPM fractions.

Western blot analysis was used to determine if any changes in expression of PKA
regulatory subunits occurred in hippocampal crude SPM during SE. Comparing samples
from control, 20,40 and 70-minute animals indicated that there was no significant change
in protein expression.

C

20

40

70

11OKd
80
47
32

SE does not result in altered PKA regulatory subunit expression in hippocampal
crude SPM fractions

Figure 7D. SE does not result in significantly altered PKA regulatory subunit
expression in hippocampal crude SPM fractions.
There was some variation in expression of PKA regulatory subunits in
hippocampal crude SPM fractions. However, no statistically significant differences were
noted between control samples and samples from any time point studied. This data
indicates that during the progression of SE, PKA expression is not significantly altered in
the hippocampus.
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SE does not result in significantly altered PKA regulatory subunit expression in
hippocampal crude SPM fractions

DISCUSSION
Through electrographic mapping of seizure progression in the Pilo-SE model this
study demonstrated an increase in PKA activity without an increase in total PKA protein.
This suggests some form of post-translational modification occurring during the
progression of SE which results in a dramatic increase in kinase activity. The results also
showed a delayed increase in synaptic PKA activity over the progression of SE. This
increase in activity was also not associated with an increase in protein concentration.
Since prolonged seizure activity observed in SE has been shown to induce spontaneous
recurrent seizures (SRS), the increase in PKA activity associated with late stages of SE
could play a role in the development of these recurrent epileptic seizures. These
observations suggest that these changes could lead to more permanent changes associated
with seizure disorders.
One possible outcome from the cellular changes seen in SE is an imbalance in the
regulation of membrane excitability. It has been shown previously that total CaMKII
activity decreases significantly coincident with the onset of SE (Singleton et al. 2005a).
In addition there is an early maintenance of PKA activity during SE with a subsequent
increase in activity at later stages. This results in a change in regulation of a variety of
cellular proteins. For example, CaMKII has been shown to positively regulate the
function of GABAAreceptors causing increased inhibitory currents (Wang et al. 1995),
and increased agonist (Churn and DeLorenzo 1998) and allosteric modulator binding
(Churn et al. 2002). At the same time, PKA has been shown to inhibit GABAAreceptor
channel function depending on the subunit composition (Kapur and Macdonald 1996).
Together, these changes in CaMKII and PKA activities would result in a decreased

GABAergic inhibitory input thus creating an imbalance the regulation of membrane
excitability. This data is mirrored by the findings that there is a complete loss of
benzodiazepine efficacy during SE which act primarily on GABAergic receptors.
Another outcome of the differential regulation of CaMKII and PKA is in the function of
cyclic-AMP response element binding protein (CREB). Both PKA and CaMKII have
been shown to phosphorylate CREB at Ser-133 (Shaywitz and Greenberg 1999). This
activates the protein allowing for entry into the nucleus to induce gene transcription. At
the same time CaMKII has been shown to phosphorylate an additional site on CREB,
Ser- 142, resulting in the inhibition of the enzyme (Dash et al. 1991; Sheng et al. 1991;
Sun et al. 1994). Thus, CaMKII and PKA play antagonistic roles in the function of this
protein and the subsequent synthesis of new proteins. The observed decrease in total
CaMKII activity and increased PKA activity seen in SE could result in the net activation
of CREB, thereby allowing for gene transcription and new protein synthesis. Support for
this could lie in the apparent translocation of PKA away from the synapse seen after 40
minutes of SE. It is possible that PKA leaves the synapse and moves out into the
cytoplasm where the majority of CREB is located. Further studies will be required to
determine if there is an increased level of CREB phosphorylation and if a detectable
increase in PKA protein is noticed in other subcellular fractions at this time.
An alternative hypothesis is that the cellular changes seen in the Pilo-SE model
represent a pathological extension of long-term potentiation (LTP). Formation of LTP
has been shown to be dependent on the actions of CaMKII and PKA. CaMKII activation
has been shown to be required for the induction of early stages of LTP (Barria et al. 1997;
Chen et al. 2001; Lisman et al. 2002; Soderling and Derkach 2000). This increase in

activity results in an increased phosphorylation levels of a-amino-3-hydroxy-5-methyl-4isoxazoleproppionate (AMPA) receptors causing an increase in receptor function. This
leads to altered membrane excitability and plasticity changes. Other factors are required
to make the plasticity changes and alterations in membrane excitability more permanent.
Progression into later stages of LTP has been shown to be dependent on an increase in
PKA activity (Duffy and Nguyen 2003; Huang et al. 2000; Matsushita et al. 2001). This
progression into late-LTP involves, among other events, an increase in neurotransmitter
release (Kuromi and Kidokoro 2000; Thakur et al. 2004), increased ion channel insertion
(Crump et al. 2001; Esteban et al. 2003), increased ion channel conductance (Meuth et al.
2002) and new protein synthesis (Kang and Schuman 1996; Krug et al. 1984; Otani et al.
1989). This shows that through multiple tetanic stimulations synapses can be selectively
potentiated and progress from a state of learning to one of memory consolidation.
It is possible that the multiple discrete seizures and subsequent prolonged seizure
activity in the Pilo-SE model represent a pathological extension of synaptic LTP. In this
analogy, the expression of discrete seizure activity would act like whole-brain tetanic
stimulation. This would result in increased CaMKII activity and induce prolonged
seizure activity. Thus resulting in increased PKA activity leading to maintenance of a
prolonged increase in membrane excitability. CaMKII activity in the synapse has been
shown to increase coincident with the onset of SE (Singleton et al. 2005a). As seizure
activity progresses, we have observed a significant increase in synaptic and total PKA
activity. These discrete seizures could represent the tetanic stimuli that are required for
the formation of LTP in synapses and single cells. However, instead of potentiating a

single cell or synapse, discrete seizures would potentiate all of the synapses of a given
brain region.
If these changes result in the potentiation of thousands of synapses across whole
brain regions, it could lead to the formation of a whole brain LTP-like event. This would
result in the synchronization of the synapses and result in thg formation of seizures. SE
has been shown to be an ideal model for use in inducing epileptogenesis (Rice and
DeLorenzo 1998; Turski 2000). Epileptogenesis is the process by which individuals
develop spontaneous recurrent seizures (SRSs). Since SRSs have been shown to occur
following SE and the data here show that changes associated with the formation of LTP
also occur during SE, there is a possibility that SE results in the formation of a whole
brain LTP-like event. The progression from early stages of SE to late stages with
accompanying cellular changes could cement alterations in membrane excitability across
the entire brain. This would result in an increased occurrence of spontaneous seizures
referred to as epilepsy.
An additional point of interest is the relationship between the changes in PKA
activity and the progression of the seizure profile seen in the Pilo-SE model. While PKA
activity is maintained during the early phases of SE, PKA activity increases roughly
coincident with the onset of the F S P phase of SE. This indicates that a large-scale PKA
activity change could either push the seizure progression into later stages or prevent SE
activity from reverting back to earlier, less pathological phases. To further analyze this
relationship, PKA activity should be studied in those animals that do not enter the later
seizure profile stages of SE. It has been shown that young rats (postnatal day 30) are
much less likely to enter late phases of SE primarily progressing only to the EC phase

(Holbert I1 et al. 2004). In addition, younger animals have also been shown to be less
likely to develop spontaneous recurrent seizures following SE than older animals (Sankar
et al. 2000). If no increase in PKA activity after 40 minutes of SE is noticed in these
animals, it could indicate that the increase in PKA activity seen in adult animals may
have a causative effect on the progression through late stages of SE. This would provide
further evidence that SE treatments targeted towards PKA could have a positive impact
on reducing seizure severity and possibly reduce the occurrence of spontaneous recurrent
seizures.
The findings in this paper characterize both the EEG and phosphorylation studies
of a time dependent SE-induced increase in PKA activity. During early periods of SE,
when total CaMKII activity is observed to decrease, PKA activity is maintained. Later in
the progression of SE, PKA activity is observed to increase significantly. This indicates
that PKA could provide a neuronal marker for the development of later, more
pathological stages of SE and possibly give an indication as to susceptibility of
epileptogenesis. In addition to the increase in PKA activity seen in both the homogenate
and crude SPM samples, there is no associated increase in PKA protein levels. This
indicates that the increase in PKA activity is the result of some yet to be determined posttranslational modification mechanism.

DISCUSSION
PKA changes associated with late stages of status epilepticus
This study was performed to examine the relationship between PKA activity and
the development of status epilepticus (SE). Previously our lab has shown that coincident
with the onset of SE, there is an immediate decrease in CaMKII activity on a whole cell
level (Singleton et al. 2005a). Because it has been shown that CaMKII positively
modulates the function of GABAergic receptor function (Churn and DeLorenzo 1998;
Churn et al. 2002; Wang et al. 1995), a decrease in CaMKII activity may result in
decreased inhibitory neuronal signaling. At the same time, it is known that PKA can also
cause the inhibition of GABAergic receptors depending on subunit composition (Kapur
and Macdonald 1996; Tehrani and Barnes 1995). Taken together, loss of CaMKII
activity and either maintenance or an increase in PKA activity would result in the
alteration of normal neuronal membrane excitability as is seen in seizure states. It was
our hypothesis that during SE PKA activity is maintained to offset the decrease in total
CaMKII activity thus resulting in altered regulation of membrane excitability. The
results from this study indicate that not only is PKA activity maintained during the early
stages of SE, there is an appreciable increase in PKA activity during later stages of SE
progression. This interesting finding could be significant for a variety of reasons
including a possible link between the developmental progression of SE and the induction
of stages of long-term potentiation (LTP).
This study showed that in the rat pilocarpine model of SE, PKA activity is
maintained during approximately the first 20-30 minutes of seizure activity. Following
this time there is a significant increase in the level of PKA activity in cortical whole

tissue homogenates. Hippocampal samples showed a similar trend but did not reach
significance in total PKA activity. Western blot analysis of cortex and hippocampal
homogenates revealed no significant change in PKA subunit expression (either catalytic
or regulatory) in any of the time points studied. This indicates that synthesis of new PKA
protein is not responsible for the increase in kinase activity.,
PKA activity assays in cortical crude synaptic fractions displayed results similar
to those seen in the homogenate samples. Cortical crude SPM activity was observed to
remain at control levels during the initial stages of SE. After 40-minutes of seizure
activity, however, PKA activity is shown to increase significantly. Western analysis of
crude synaptic fractions revealed slightly different results than those seen in the
homogenate. PKA protein concentration for both catalytic and regulatory subunits
remained relatively constant for early periods of SE. After 40 minutes of seizure activity,
however, there is a significant decrease in protein concentration in the cortical synaptic
fractions. This decrease appears transient due to the return of PKA protein levels to near
control values after 70 minutes of seizure activity. PKA activity and protein
concentration in hippocampal samples were maintained at near control levels for all time
points studied. The data indicate that late stages of SE result in increased activation of
PKA through some form of post-translational modification mechanism and also suggest
that there is some level of PKA translocation away from the synapse. Combined with the
fact that CaMKII activity decreases at the onset of SE, these data indicate that the cellular
changes observed during SE could lead to improper regulation of membrane excitability.
LTP - SE relationship

Another hypothesis for the cellular changes associated with SE involves the
formation of long-term potentiation. Extensive research has shown that CaMKII and
PKA activation are required for the formation of different stages of LTP (Huang and
Kandel 1994; Wikstrom et al. 2003; Yang et al. 2004). In early stages of SE, CaMKII is
responsible for the positive modulation of AMPA receptor qhannels. Activated via ca2'
influx through N-methyl-D-aspartate receptor channels (NMDA), CaMKII
phosphorylates AMPA receptors resulting in increased channel function and the
induction of LTP (Derkach et al. 1999; Soderling and Derkach 2000). Formation of later
stages of LTP has been shown to be dependent primarily on new protein synthesis which
is accomplished through a PKA dependent mechanism (Frey et al. 1988; Nguyen et al.
1994; Woo et al. 2002). PKA works to maintain early stages of LTP through reversible
phosphorylation of membrane ion channels and triggers synthesis of new proteins
through phosphorylation of transcription factors such as cyclic-AMP response element
binding protein (CREB). This leads to the transcription of genes and the eventual
translation of mRNA into proteins. This has been shown to be especially prevalent in
dendritic spines during late-LTP, although the mechanism and identity of translated
mRNAs is still largely unresolved (Frey et al. 1988; Nguyen et al. 1994; Tsokas et al.
2005; Woo and Nguyen 2003). The combination of the increased CaMKII and PKA
activities results in the strengthening of synaptic signaling. This results in synapses
converting from a state of learning to one of memory consolidation.
In light of the fact that both CaMKII and PKA show an increase in synaptic
activity during the formation of LTP as well as in the Pilo-SE model, it makes one
wonder if there is a relationship between the two and if SE could be a pathological

extension of LTP. High frequency stimulations have been shown to induce LTP through
the activation of CaMKII in neurons (Fukunaga et al. 2002; Fukunaga et al. 1995; Havik
et al. 2003). In an analagous manner, CaMKII activity is observed to increase in synaptic
fractions coincident with the onset of SE. SE is typically preceded by a series of 2-3
discrete seizures. These seizures are brief, 10-50 seconds, and contain high amplitude
spiking (Singleton et al. 2005b). When repeated, these discrete seizures could be acting
to stimulate CaMKII activation on a whole-brain level in the same manner as high
frequency stimulation of synapses in LTP paradigms. Interestingly animals that
experience discrete seizures, but fail to enter into SE do not display a change in either
CaMKII or PKA activity. This could suggest that either a certain severity of discrete
seizure is required for the increase in CaMKII activity or that CaMKII activity increases
as a result of the transformation from discrete seizures to the continuous seizure activity
of SE. In addition this study shows that PKA activity increases after prolonged seizure
activity and after the increase in CaMKII activity subsides. This increase in PKA activity
could lead to the synthesis of new proteins required for the induction of later stages and
maintenance of LTP. SE has been shown to be an accurate model to induce
epileptogenesis (Rice and DeLorenzo 1998; Turski 2000). Due to this, the occurrence of
discrete seizures followed by an increase in CaMKII and PKA activities could result in
the transformation of SE into a potentiated seizure condition, epilepsy, in an LTP-like
manner.
Possible cellular changes associated with SE
During SE there are many changes occurring within neurons producing a myriad
of cellular alterations. Included in these are changes in the activity levels of several

protein kinases and phosphatases, notably, CaMKII, PKA and calcineurin (CaN).
Coincident with the onset of SE, total CaMKII activity is observed to decrease while
synaptic activity increases before decreasing over time (Singleton et al. 2005a). This can
result in a variety of changes in the cell. CaMKII has been shown to pl~ospl~orylate
AMPA receptors at the Ser-83 1 site. This causes a positive regulation of ion influx
+ ca2+currents. Activation
through these channels resulting in increased inward ~ a and
of CaMKII has also recently been shown to transiently phosphorylate the translation
factor cytoplasmic polyadenylation element binding protein (CPEB) (Atkins et al. 2005).
This results in new protein synthesis including new dendritic spine formation. If
CaMKII activation is not sustained however, this activation of CPEB is lost after a short
time (Atkins et al. 2005). In addition, CaMKII has been shown to phosphorylate CREB
(primariy associated with PKA) at two sites and is traditionally thought to inhibit CREB
function (Dash et al. 1991; Sheng et al. 1991; Sun et al. 1994). Loss of CaMKII activity
would disinhibit CREB thus allowing it to take over for the now inactivated CPEB.
Since loss of CaMKII is seen during the progression of SE, membrane excitability and
new protein synthesis must be regulated in other ways. An increase in PKA activity seen
at later stages of SE is a plausible option.
PKA has been shown to cause an increase in protein synthesis and increased
membrane excitability in a variety of ways. First, PKA's main path to protein synthesis
is through the phosphorylation of CREB. This allows CREB to enter the nucleus, bind
CRE sites, and initiate gene transcription. PKA can also affect the CaMKII activation of
CPEB, by maintaining its level of phosphorlyation. Normally CPEB is dephosphorylated
by protein phosphatase 1 (PP1). PKA acts to inhibit PP1 through the activation of

dopmanine and CAMP-regulated phosphoprotein -32 (DARPP-32) and inhibitor 1.
Activation of this family of proteins causes the inhibition of PP1 resulting in a
maintenance of phosphorylation of CPEB. This mechanism is also responsible for
maintaining the activation of AMPA receptors regulated through phosphorylation by
CaMKII (Vinade and Dosemeci, 2000). These two events result in an increase in ion
conductance as well as new protein synthesis.
In addition to the SE-induced changes in CaMKII and PKA activity, there are
significant changes observed in protein phospliatase 2B or calcineurin (CaN). CaN has
been associated with the modulation of function of both GABA and NMDA receptors
(Huang and Dillon 1998; Krupp et al. 2002; Lu et al. 2000; Umemiya et al. 2001) and is
also involved in regulating the release of neurotransmitters (Cordeiro et al. 2000), gene
transcription (Clipstone and Crabtree 1992; Jain et al. 1993) and cytoskeletal architecture
(Drewes et al. 1993; Goto et al. 1985; Mandelkow et al. 1995). Roughly coincident with
the increase in PKA activity, CaN activity is observed to increase in both basal and
maximal reactions (Kurz et al. 2001). This increase has several effects within the cell.
First, CaN causes the activation of cofilin which leads to actin depolymerization in
dendritic spines (Wang et al. 2005). This is often seen in neuronal degeneration
associated with traumas such as seizures. In addition, CaN acts to reduce AMPA
receptor ion conductance through the disinhibition of PP1. This is in direct contrast to
the action of PKA on PP1. Since seizures are observed to continue after this 30-40
minute time point, PKA activity could overpower that of CaN and cause the continued
excitation of glutamatergic receptor function. CaN also plays a role in the regulation of
new protein synthesis. CaN is able to inactivate CREB through the disinhibition of PP1,

however, this only occurs following weakly stimulated synapses and cells (Hagiwara et
al. 1992; King et al. 1984). It has also been reported that inhibition of CaN results in the
enhancement of learning and memory and LTP (Malleret et al. 2001). This indicates that
the increase in CaN activity seen during SE progression could be an attempt to reduce the
long term effects of the seizures which are possibly caused through a PKA dependent
mechanism.
Regulation of PKA activity
Regulation of PKA activity .throughNMDA receptor mediated ca2+entry is
complex. ca2+can cause the activation of adenylate cyclases resulting in the formation
of cAMP which leads to the activation of PKA. At the same time, this influx of ca2' can
lead to the activation of calmodulin dependent phosphodiesterases (PDEs) which leads to
a decrease in cAMP levels. This phenomenon is counterbalanced through the activation
of CaMKII which inhibits the PDEs (Hashimoto et al. 1989). Since CaMKII activity is
observed to decrease early in SE progression it is unlikely that this mechanism is what
maintains PKA activity during the later stages of SE. Further reports suggest that PKA
can be autoregulated. Activation of PKA can lead to phosphorylation of the regulatory
subunits by the catalytic subunits thereby reducing their binding affinity (First et al.
1988). Attempts were made during this study to look at the levels of PKA regulatory
subunit phosphorylation, however, no reliable results were ever obtained. Additionally, it
has been shown that there is selective degradation of PKA regulatory subunits through
ubiquitination (Chain et al. 1999; Chain et al. 1995; Hegde et al. 1993; Hegde et al.
1997). This results in the reduction of the regulatory to catalytic subunit ratio which
would lead to prolonged activation. This is plausible considering the decrease in PKA

regulatory subunit expression seen in the crude SPM after 40-minutes of SE, but does not
explain the return to control levels at 70-minutes. Further studies are required to
determine if the PKA protein is translocating away from the synapse then back between
40 and 70-minutes or, alternatively, if the protein is being degraded by some mechanism
and then resynthesized.

,

The cellular changes listed here are but a few of the many effects that these
kinases and phosphatases have on the cell at any given time. Further research is required
to fully elucidate the relationship between all of these enzymes and the impact that the
progression of SE has on each.
Future Areas of Research
To date there has been little research that focuses on the role PKA plays in the
progression of SE and its affect on the formation of spontaneous recurrent seizures. This
study focuses on a temporal relationship between SE progression and PKA activity in
adult animals. The data suggest that the significant increase in PKA activity could result
in further progression through SE and that PKA may play a role in the formation of more
permanent seizure states. In light of this, there are several additional areas of interest for
future study.
The PKA activity assays used in this study employed an exogenous substrate. To
characterize more thoroughly the effects of the increased PKA activity, a variety of
endogenous substrates could be observed for changes in phosphorylation level during the
progression of SE. For example, new protein synthesis has been shown to be required for
the induction and maintenance of late-LTP (Huang et al. 2000). This is a PKA dependent
process acting through cyclic-AMP response element binding protein (CREB). An

increase in the level of phospho-CREB at late stages of SE would provide further
evidence that the increase in PKA activity is playing a role in the long-term maintenance
of a pathological extension of LTP. Phospho-CREB specific antibodies are commercially
available to facilitate this study. At the same time, there are a variety of ion channels that
are directly or indirectly regulated by PKA. AMPA channels are known to be
phosphorylated by CaMKII at Ser-83 1. This level of phosphorylation is regulated by the
action of protein phosphatase 1 (PP 1) which is activated through a disinhibition by
calcinuerin. PKA regulates this process by phosphorylating Inhibitor l/DARPP-32
family members which inhibits the activity of PPl (Vinade and Dosemeci 2000). SE
could produce an increased phospho-inhibitor 1 or phospho-DARPP-32 level which
would lead to maintained ion currents through AMPA channels and this sustained
excitability and altered membrane potential. This mechanism would also cause the
maintenance of CPEB activation, a CaMKII dependent transcription factor, which is
inactivated via dephosphorylation by PP1.
Additionally, there are amino acid residues on both AMPA and NMDA channels
reported to be specific for interaction with PKA. On AMPA channels, Ser-845 is a PKA
specific site. Phosphorylation at this site causes, by some accounts, increased receptor
insertion and increased anchoring of the receptor to the postsynaptic density (Vinade and
Dosemeci 2000). It would be of interest to determine if, during the course of SE, there is
an increased phosphorylation level of AMPA receptors at the PKA specific site. This
would give a further causative mechanism for the increased and continued membrane
excitability associated with prolonged seizures. Furthermore, PKA has been shown to
increase insertion and clustering of NMDA channels (Crump et al. 2001; Tingley et al.

1997). Similar to AMPA channels, analysis of phosphorylation levels of NMDA
channels at PKA specific sites during SE could shed further light on the mechanism
behind the imbalanced regulation of neuronal membrane excitability. Again phosphoAMPA and phospho-NMDA specific antibodies are available for this purpose.
Conclusions
This study shows that prolonged episodes of status epilepticus result in an
increase in protein kinase A activity without the synthesis of significant amounts of new
PKA protein. This indicates that during SE some form of post-translational modification
mechanism is occurring that results in the increased activity. This increase in PKA
activity is subsequent to a decrease in total CaMKII activity and initial increase in
synaptic CaMKII activity. Decreased total CaMKII activity combined with increased
PKA activity can lead to an imbalance in membrane excitability regulation as is seen in
seizure states. An early increase in synaptic CaMKII activity combined with a
subsequent PKA activity increase in the Pilo-SE model indicates that progression through
SE could be acting as a pathological extension of LTP. These results support the
hypothesis that PKA is involved in the progression of SE and may play a role in the
process of epileptogenesis.
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